To determine whether women with multiple sclerosis (MS) diagnosed according to current criteria are at an increased risk of postpartum relapses and to assess whether this risk is modified by breastfeeding or MS disease-modifying therapies (DMTs), the authors (Neurology. 2020 May 5;94(18):e1939-e1949) examined the electronic health records (EHRs) of...
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a significant burden for those affected and a great economic cost for the society.
The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder (NMSD).
Adding yoga to a standard medication regimen is significantly better than medication alone in providing migraine relief, results of a randomized controlled trial show (Neurology. Published online May 6).
A recent study published in CNS drugs ( Chen MH, Goverover Y, Genova HM, DeLuca J) concludes that there is not enough evidence to support the use of drug treatments to improve the cognitive function of people with MS.
MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation
A number of risk factors established for multiple sclerosis (MS) may also be valid for the process of evolution from a clinically isolated syndrome; these factors include low levels of vitamin D, smoking, and Epstein-Barr virus (EBV) infection. They interact with genetic risk factors, mainly Class II human leukocyte antigen (HLA) alleles. Some...
A new meta-analysis has concluded that the benefit of statin therapy in the prevention of ischemic stroke "greatly exceeds" the risk for intracerebral hemorrhage (ICH).
Albuminuria is a marker for endothelial dysfunction and knowledge on its association with stroke and stroke subtypes are limited.
A 50-year-old man developed Miller Fisher syndrome and a 39-year-old man developed polyneuritis cranialis.
